EichorEICHOR
Study identifier: NCT05279313 Synced from ClinicalTrials.gov · August 05, 2026
● Completed

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

Condition: Attention Deficit/Hyperactivity Disorder  ·  Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

PhasePhase 3
Planned participants680
Who can joinAll sexes, 4 Years to 18 Years
Healthy volunteersNo

About this study

To evaluate long-term safety exposure

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (86)

Harmonex Neuroscience ResearchDothan, Alabama, United States
The Center for Clinical Trials, Inc.Saraland, Alabama, United States
Southwest Autism Research and Resource CenterPhoenix, Arizona, United States
Preferred Research Partners, Inc.Little Rock, Arkansas, United States
Woodland International Research GroupLittle Rock, Arkansas, United States
Care AccessBeverly Hills, California, United States
Proscience Research GroupCulver City, California, United States
Sun Valley Research Center, Inc.Imperial, California, United States
Long Beach Clinical Trials Services, IncLong Beach, California, United States
NRC Research InstituteOrange, California, United States
SDS Clinical Trials IncSanta Ana, California, United States
CMB Clinical TrialsSantee, California, United States

+ 74 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →